Renalytix Plc
RNLXY
Revenue
586.00k
▲51.00k▲9.53%
3 Months ChangeAssets
7.97M
▼-797.00k▼-9.09%
3 Months ChangeLiabilities
15.83M
▼-4.05M▼-20.39%
3 Months ChangeFree Cash Flow
-34.09M
▲12.40M▲26.67%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-01
Form 8-K
ID: 0001193125-24-230319
2024-08-27
Form 8-K
ID: 0000950170-24-100790
2024-07-15
Form 8-K
ID: 0000950170-24-083385
2024-06-24
Form 8-K
ID: 0000950170-24-076884
2024-06-24
Form 8-K
ID: 0000950170-24-076873
2024-06-17
Form 8-K
ID: 0000950170-24-074280
2024-06-12
Form 8-K
ID: 0000950170-24-072531
2024-05-28
Form 8-K
ID: 0000950170-24-064882
2024-05-15
Form 8-K
ID: 0000950170-24-060084
2024-05-15
Form 10-Q
ID: 0000950170-24-060033